Sudden hearing impairment combined with diabetes mellitus or hyperlipidemia

European Archives of Oto-Rhino-Laryngology

Volumn 264, Issue 4, 2007, Pages 359-362

  Orita, Saeko ^a   Fukushima, Kunihiro ^a   Orita, Yorihisa ^a,b   Nishizaki, Kazunori ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Hypercholesterolemia; Hyperglycemia; Microvascular disorder; Sudden deafness

Indexed keywords

ADENOSINE TRIPHOSPHATE; HETASTARCH; HYDROCORTISONE SODIUM SUCCINATE; MECOBALAMIN; PROSTAVASIN;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEARING ACUITY; HUMAN; HYPERBARIC OXYGEN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROANGIOPATHY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SUDDEN DEAFNESS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CAPILLARY PERMEABILITY; CHILD; COMORBIDITY; DIABETES MELLITUS; DINOPROSTONE; EAR, INNER; FEMALE; HEARING LOSS, SUDDEN; HUMANS; HYPERBARIC OXYGENATION; HYPERCHOLESTEROLEMIA; MALE; MICROCIRCULATION; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASES;

EID: 33847649549     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-006-0196-6     Document Type: Article

References (20)

1. Aslan I, Oysu C, Veyseller B et al (2002) Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness ? Otolaryngol Head Neck Surg 126:121-126
2. Centers for Disease Control, Prevention (CDC) (2005) Trends in cholesterol screening and awareness of high blood cholesterol-United States, 1991-2003. MMWR Morb Mortal Wkly Rep 54:865-870
3. Deramo VA, Sergott RC, Augsburger JJ et al (2003) Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology 110:1041-1046
4. Erdem T, Ozturan O, Miman MC et al (2003) Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur Arch Otorhinolaryngol 260:62-66
5. Harmel AP (2002) Treating diabetes: cardiovascular benefits of antidiabetes drugs. Am J Manag Care 8 (8 Suppl): S219-S228; quiz S229-S232
6. Hirano K, Ikeda K, Kawase T et al (1999) Prognosis of sudden deafness with special reference to risk factors of microvascular pathology. Auris Nasus Larynx 26:111-115
7. Kalaria RN (2002) Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 13(Suppl 2):48-52
8. Kanzaki J, Inoue Y, Ogawa K et al (2003) Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 30(2):123-127
9. Kendall DM, Bergenstal RM (2001) Comprehensive management of patients with type2 diabetes: establishing priorities of care. Am J Manag Care 7(Suppl 10):S327-S343
10. Kronenberg J, Almagor M, Bendet E et al (1992) Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 102:65-68
11. Kubo T, Matsunaga T, Asai H, et al (1988) Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 114:649-652
12. Nomura Y (1988) Diagnostic criteria for sudden deafness, mumps deafness and perilymphatic fistula. Acta Otolaryngol (Stockh) Suppl 456:7-8
13. Robert WV, William RW, Philip MS et al (1981) The implication of viruses in idiopathic sudden hearing loss: primary infection or reactivation of latent viruses. Otolaryngol Head Neck Surg 89:137-141
14. Rust KR, Triana RJ, Michaelis IV OE et al (1992) Inner ear damage secondary to diabetes mellitus. II. Changes in aging SHR/N-cp Rats. Arch Otolaryngol Head Neck Surg 118:397-400
15. Schweinfurth JM, Cacace AT (2000) Cochlear ischemia induced by circulating iron particles under magnetic control: an animal model for sudden hearing loss. Am J Otol 21:636-640
16. Snow V, Aronson MD, Hornbake ER et al (2004) Lipid control in the management of type2 diabetes mellitus: a clinical practice guideline from the American college of physicians. Ann Intern Med 140:644-649
17. Suzuki K, Kaneko M, Murai K (2000) Influence of serum lipids on auditory function. Laryngoscope 110:1736-1739
18. Vinters HV, Ellis WG, Zarrow C et al (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931-945
19. Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 106:772-776
20. Glucose tolerance, mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DE-CODE study group. European Diabetes Epidemiology Group (1999) Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354:617-621